Related references
Note: Only part of the references are listed.Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome
Lauro Meneghel et al.
CLINICA CHIMICA ACTA (2015)
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
Maria Laura Bertolaccini et al.
AUTOIMMUNITY REVIEWS (2014)
Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome
R. Mondejar et al.
CLINICA CHIMICA ACTA (2014)
Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies
P. Fontana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH
K. M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Domain I: the hidden face of antiphospholipid syndrome
C. Pericleous et al.
LUPUS (2014)
Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation
R. Forastiero
LUPUS (2014)
Standardization of Antiphospholipid Antibody Testing-Historical Perspectives and Ongoing Initiatives*
Rohan Willis et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)
New Tests to Detect Antiphospholipid Antibodies: Anti-Domain I Beta-2-Glycoprotein-I Antibodies
Cecilia Beatrice Chighizola et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome
Savino Sciascia et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs
Leonie Pelkmans et al.
PLOS ONE (2013)
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Kotaro Otomo et al.
ARTHRITIS AND RHEUMATISM (2012)
Autoantibodies to domain 1 of beta 2 glycoprotein 1: A promising candidate biomarker for risk management in antiphospholipid syndrome
Michael Mahler et al.
AUTOIMMUNITY REVIEWS (2012)
Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome
F. Van Hoecke et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2012)
Antibodies against domain I of β2-glycoprotein I: the one and only?
L. Pelkmans et al.
LUPUS (2012)
Standardization of antiphospholipid antibody assays. Where do we stand?
K. M. J. Devreese
LUPUS (2012)
Antiphospholipid antibodies: Evaluation of the thrombotic risk
Katrien M. J. Devreese
THROMBOSIS RESEARCH (2012)
Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile?
Laura Andreoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays
Katrien M. J. Devreese et al.
THROMBOSIS RESEARCH (2011)
Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)
A. Banzato et al.
THROMBOSIS RESEARCH (2011)
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
B. De Laat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy
A. Ruffatti et al.
THROMBOSIS RESEARCH (2009)
Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification
A. Ruffatti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change
B de Laat et al.
BLOOD (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
The presence of IgG antibodies against β2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant
C Zoghlami-Rintelen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis
B de Laat et al.
BLOOD (2005)
β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome
HB de Laat et al.
BLOOD (2004)
Use of single point mutations in domain I of β2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies
GM Iverson et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
